OIC Launches One Procedure, One Price(TM) Initiative

  • Home
  • Blog
  • OIC Launches One Procedure, One Price(TM) Initiative

Driving Orthopaedic Procedure Costs Down: OIC Launches One Procedure, One Price(TM) Initiative

The Orthopaedic Implant Company

Driving Orthopaedic Procedure Costs Down: OIC Launches One Procedure, One Price(TM) Initiative

The Orthopaedic Implant Company (OIC) today announced the launch of the One Procedure, One Price™ initiative designed to reduce the expense of orthopaedic procedures and create a new standard cost of care that benefits patients, physicians, and hospitals.

The cost of healthcare has created financial burdens that often cannot be overcome. Hospitals are accumulating massive financial deficits. Surgeons are forced to fit more procedures into less time. Patients are plagued with healthcare costs that are ruining lives after life-improving procedures. The One Procedure, One Price initiative is changing this dynamic and creating a more equitable landscape.

“In orthopaedic procedures, commoditized implants are typically the most significant expense. Medical devices companies have put exorbitant price tags on implants and tools differentiated by sales and marketing expenses, not innovative technology. At OIC, we will not justify this approach,” said Itai Nemovicher, President and CEO of OIC. “That’s why we launched our One Procedure, One Price initiative creating a single price for the construct of parts used during an orthopaedic surgical procedure. We’re removing the guesswork of pricing and cost, and creating an opportunity for transparency, margin improvement, and lower cost of care.”

One Procedure, One Price packages all of the elements needed to complete a procedure at one price - plates, screws, drill bits, and fixation pins. OIC implants are made with medical-grade materials, FDA-approved processes, quality systems, ASTM, and ISO standards, and often in the same facilities as higher-priced competitive devices. Additionally, OIC implant systems are designed to be comprehensive, yet incredibly intuitive. The result is implant solutions designed to work with all the other product hardware, helping streamline operating room processes and further reducing costs.

“We’re shining the light on the gluttonous financial practices long considered normal in the orthopaedic industry,” added Nemovicher. “We are committed to disrupting the norm, driving accountability among orthopaedic device manufacturers and helping minimize the financial burden of healthcare that is devastating the United States.”

A study published in the Journal of Orthopaedic Trauma found over the course of a year, the use of OIC implants with a construct pricing structure resulted in a 56 percent savings compared to the average cost of competitive device offerings. A similar study by the University of Nevada - Reno showed a 51 percent reduction in operative time compared to conventional implants, resulting from the self-contained product line.

The Orthopaedic Implant Company (OIC) is changing the way orthopaedic implants are delivered and priced. OIC creates better value for the implants known and used every day. The company’s dynamic, human-focused strategy begins and ends with prioritizing people, not numbers. The team is comprised of industry experts who bring together decades of combined experience to create change in a healthcare system that must evolve.

(RENO, NV, July 29, 2020 /Accesswire/Source: The Orthopaedic Implant Company)



You May Also Like

Zimmer Biomet Names CEO of Dental/Spine Spin-Off: Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that after an extensive search, Vafa Jamali has been appointed as CEO of "NewCo", the independent, publicly traded company that will be created by ... Read More

Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance: "I am very pleased that the CE mark has been secured for Bactiguard-coated Zimmer Biomet trauma implants. This clearance will pave the way for European market launch in 2021. At the same time, we are preparing for the submission of the U.S regulatory file ... Read More

A new non-surgical treatment to lessen patient’s pain and get them back to their active lifestyles: Miller Orthopedic Specialists introduces MOS Regenerative Medicine Solutions, a non-surgical treatment that uses a patient’s own stem cells to promote healing within. MOS Regenerative Medicine Solutions has multiple types of treatments that... Read More

Syntellix Lauded by Frost & Sullivan for its Bioresorbable Orthopedic Implant: The innovation reduces surgical complications and time in the OR without any major changes to standard procedures - all while decreasing healthcare costs. The MAGNEZIX implant's unique capability of converting metal to bone makes it an ideal implant of the future ... Read More

Trauma Implants Market to Reach 10.14 Billion by 2026: The global Trauma Implants Market size is expected to reach USD 10.14 billion by 2026, exhibiting a CAGR of 4.3% during the forecast period. The increasing prevalence of sports injuries among children and teenagers will contribute significantly to the Trauma Implants Market share in the forthcoming years... Read More

The Coronavirus has increased the focus on healthcare and modern equipment: Globally, no sector has been placed under the magnifying glass more than the healthcare sector due to the Corona pandemic. Hospitals, outpatient clinics, practice-based physicians and care facilities have experienced a sudden increased demand for medical and laboratory technology... Read More

Video of the Week

Video helps you make a human connection with your viewers.